HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 51 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $221 | +198.6% | 284,300 | +15.8% | 0.00% | – |
| Q4 2022 | $74 | -99.9% | 245,600 | +5.8% | 0.00% | – |
| Q3 2022 | $117,000 | -12.7% | 232,100 | -1.1% | 0.00% | – |
| Q2 2022 | $134,000 | -17.8% | 234,600 | +85.3% | 0.00% | – |
| Q1 2022 | $163,000 | +186.0% | 126,600 | +151.7% | 0.00% | – |
| Q4 2021 | $57,000 | -80.3% | 50,300 | -68.1% | 0.00% | – |
| Q1 2021 | $290,000 | -59.8% | 157,500 | -52.1% | 0.00% | -100.0% |
| Q4 2020 | $721,000 | +212.1% | 329,022 | +664.5% | 0.00% | – |
| Q4 2019 | $231,000 | – | 43,039 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 189,616 | $375,439,000 | 1.17% |
| Ikarian Capital, LLC | 1,365,059 | $2,703,000 | 0.22% |
| Altium Capital Management LP | 446,000 | $883,000 | 0.20% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 91,500 | $181,000 | 0.10% |
| Virtu Financial LLC | 113,869 | $225,000 | 0.02% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 10,000 | $20,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 155,069 | $307,000 | 0.01% |
| McAdam, LLC | 55,978 | $86,000 | 0.01% |
| Moloney Securities Asset Management, LLC | 27,340 | $54,000 | 0.01% |
| Allen Capital Group, LLC | 23,685 | $47,000 | 0.01% |